Midkine expression in high grade gliomas: Correlation of this novel marker with proliferation and survival in human gliomas.

作者: Chien-Min Chen , Dueng-Yuan Hueng , Yen-Po Cheng , Chin Lin , Ping-Yi Lin

DOI: 10.4103/2152-7806.133205

关键词: OncologySurvival analysisMedicineInternal medicinePathologyGliomaConfidence intervalPathologicalSurvival rateCarcinogenesisAngiogenesisMidkine

摘要: BACKGROUND High-grade primary glioma have poor prognosis and predictive biomarkers is very important. Midkine (MDK), a heparin-binding growth factor, important in regulating carcinogenesis, cell proliferation, mitogenesis, angiogenesis. This study aimed to identify over-expression of MDK gliomas correlate this with clinical outcomes. The authors put forward their hypothesis correlating proliferation survival novel protein. METHODS Two datasets from Gene Expression Omnibus (GEO) included human data 100 180 patients, respectively. expression, World Health Organization (WHO) pathological grade, sex, age, time were identified for statistical analysis. RESULTS A search the GEO profile revealed that expression level was statistically greater WHO grade IV compared II (P = 0.002), grades III nontumor control 0.044 P < 0.001, respectively) after adjustments using Bonferroni method. By Kaplan-Meier curve, high group had poorer outcome (2.38-fold hazard, 95% confidence interval: 1.22-4.63) than low age. CONCLUSIONS Taken together, there positive correlation between grading gliomas. Moreover, significant correlated high-grade, suggesting may be an therapeutic target.

参考文章(25)
Sandra Donnini, Rangana Choudhuri, Roy Bicknell, Marina Ziche, Hua-Tang Zhang, An Angiogenic Role for the Neurokines Midkine and Pleiotrophin in Tumorigenesis Cancer Research. ,vol. 57, pp. 1814- 1819 ,(1997)
Takashi Muramatsu, Kenji Kadomatsu, Midkine: an emerging target of drug development for treatment of multiple diseases. British Journal of Pharmacology. ,vol. 171, pp. 811- 813 ,(2014) , 10.1111/BPH.12571
T Muramatsu, Structure and function of midkine as the basis of its pharmacological effects British Journal of Pharmacology. ,vol. 171, pp. 814- 826 ,(2014) , 10.1111/BPH.12353
SHINSUKE KATO, KENJI ISHIHARA, TAKAO SHINOZAWA, HIROYUKI YAMAGUCHI, YOSHIYA ASANO, MASAYA SAITO, MASAKO KATO, TADASHI TERADA, AKIRA AWAYA, ASAO HIRANO, DENNIS W. DICKSON, SHU-HUI YEN, EISAKU OHAMA, Monoclonal Antibody to Human Midkine Reveals Increased Midkine Expression in Human Brain Tumors Journal of Neuropathology and Experimental Neurology. ,vol. 58, pp. 430- 441 ,(1999) , 10.1097/00005072-199905000-00002
Wen-Chiuan Tsai, Ying Chen, Li-Chun Huang, Herng-Sheng Lee, Hsin-I Ma, Shih-Ming Huang, Huey-Kang Sytwu, Dueng-Yuan Hueng, EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas Journal of Neuro-oncology. ,vol. 114, pp. 281- 290 ,(2013) , 10.1007/S11060-013-1184-5
Shuichi Fujita, Sachiko Seki, Mutsunori Fujiwara, Tohru Ikeda, Midkine expression correlating with growth activity and tooth morphogenesis in odontogenic tumors Human Pathology. ,vol. 39, pp. 694- 700 ,(2008) , 10.1016/J.HUMPATH.2007.09.014
Yiping Huang, Myoung Sook-Kim, Edward Ratovitski, Midkine promotes tetraspanin-integrin interaction and induces FAK-Stat1α pathway contributing to migration/invasiveness of human head and neck squamous cell carcinoma cells Biochemical and Biophysical Research Communications. ,vol. 377, pp. 474- 478 ,(2008) , 10.1016/J.BBRC.2008.09.138
Yiping Huang, Mohammad Obaidul Hoque, Feng Wu, Barry Trink, David Sidransky, Edward A. Ratovitski, Midkine induces epithelial-mesenchymal transition through Notch2/Jak2-Stat3 signaling in human keratinocytes. Cell Cycle. ,vol. 7, pp. 1613- 1622 ,(2008) , 10.4161/CC.7.11.5952
Hirokazu Hidaka, Hiroshi Yagasaki, Yoshiyuki Takahashi, Asahito Hama, Nobuhiro Nishio, Makito Tanaka, Nao Yoshida, Itzel Bustos Villalobos, Yue Wang, YinYan Xu, Keizo Horibe, Sen Chen, Kenji Kadomatsu, Seiji Kojima, Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia Leukemia Research. ,vol. 31, pp. 1045- 1051 ,(2007) , 10.1016/J.LEUKRES.2006.12.008